Michael Hoy


Previously Finance Director at Merlin Biosciences Limited, the biotech venture capital fund manager. Primarily responsible for financial management, investor liaison and reporting on €450 million of funds and a key member of the management team involved in the 2007 acquisition of Orbis Group to form Excalibur. Formerly a Finance Manager with PA Consulting, where he was involved in several acquisitions and divestments, and subsequently Financial Controller at Enviros Consulting. Michael is a Fellow of the Institute of Chartered Accountants of England and Wales (FCA) and holds a BA (Hons) in Business Studies from Middlesex.